我要投票 片仔癀药业在医疗保健行业中的票数:244
· 外 推 电 报 ·
2025-05-01 18:19:03 星期四

【片仔癀药业是哪个国家的品牌?】

片仔癀药业是什么牌子?「片仔癀药业」是 漳州片仔癀药业股份有限公司 旗下著名品牌。该品牌发源于福建,由创始人刘建顺在1555期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力片仔癀药业品牌出海!将品牌入驻外推网,定制片仔癀药业品牌推广信息,可以显著提高片仔癀药业产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

漳州片仔癀药业股份有限公司,是漳州市制药厂改制创立的,是全国“重合同、守信用”企业、国家火炬高新技术企业、福建省百家重点工业企业、居我国中成药行业50强。公司连续多年入选福建省工业主要行业竞争力十强、工业300强、工业效益300强、利税300强。公司以生产名贵中成药——片仔癀而享誉海内外,注册的“片仔癀”商标于1999年元月被评为“中国驰名商标”,2006年入选商务部首批“中华老字号”、并入选中华老字号品牌价值百强榜20强,福建省出口名牌,片仔癀系列产品首批通过国家原产地标记认证,并被评为福建省名牌产品。2002年经国家人事部批准,设立博士后科研工作站。公司股票于2003年6月16日在上海证券交易所成功上市,2003年度列全国1200多家上市公司综合绩效排名第11位,2004年被评为福建省大、中型国有及国有控股企业效绩“十佳”。

公司的主导产品——片仔癀,两度荣获国家质量金质奖,并被列入国家中药一级保护品种,其以独特的消炎、解毒、镇痛、保肝等显著疗效及保护健康的功能而深受国内外患者的赞誉,被誉为“国宝神药”,并大量出口东南亚、日本、韩国、加拿大等国家和地区,年出口创汇超千万美元,居中国中成药单项出口创汇首位。2000年片仔癀作为内地第一个获得香港政府创新及科技基金无偿资助的中成药研究项目,由香港中文大学进行片仔癀保肝作用研究。

公司视产品质量为企业的生命,严格按国家GMP规范要求组织生产。公司始终重视新药的研发和老产品二次开发工作。近年来,相继研制开发投产了包括金糖宁胶囊、心舒宝片、清热止咳颗粒、复方片仔癀含片、增乳膏等在内的十几个新产品,使公司每年都有新产品面市,老产品二次开发--片仔癀胶囊增加适应症的临床研究被国家列入“863”计划。

目前公司有如下几个系列产品:

1.片仔癀系列:片仔癀、片仔癀胶囊、复方片仔癀软膏、复方片仔癀痔疮软膏、复方片仔癀含片;

2.感冒止咳系列:清热止咳颗粒、川贝清肺糖浆、藿香正气水(胶囊)、金牡感冒片、小柴胡颗粒、板蓝根颗粒、小儿止咳糖浆等;

3.丸剂系列:六味地黄丸、杞菊地黄丸、知柏地黄丸、香砂六君丸、逍遥丸;

4.保肝护肝类:茵胆平肝胶囊、护肝片;

5.妇女儿童类:增乳膏、逍遥丸、小儿止咳糖浆;

6.心血管类:心舒宝片、复方丹参片;

7.其它:少林正骨精、牛黄解毒片、蜂乳胶囊、金糖宁胶囊等等;

8.另外还有仅供国外销售产品:龙江牌特效片仔癀暗疮膏、复方片仔癀肝宝、片仔癀活络油、片仔癀白花蛇解痒片、片仔癀润喉片、片仔癀消炎胶囊、片仔癀润喉糖、片仔癀跌打精等。

英文翻译:Zhangzhou Pianzihuang Pharmaceutical Co., Ltd. was founded by Zhangzhou pharmaceutical factory. It is a national "contract and credit" enterprise, a national torch high-tech enterprise, a hundred key industrial enterprises in Fujian Province, and one of the top 50 Chinese patent medicine enterprises in China. For many years, the company has been selected as one of the top ten industrial competitiveness, top 300 industry, top 300 industrial efficiency and top 300 profit and tax. The company is famous at home and abroad for the production of famous Chinese patent medicine - pianzehuang. The registered "pianzehuang" trademark was rated as "China's famous trademark" in January 1999. In 2006, it was selected as the first batch of "China's time-honored brand" by the Ministry of Commerce, and was listed as the top 20 in the top 100 brand value list of China's time-honored brand. Fujian Province's export famous brand, pianzehuang series of products passed the national origin mark certification in the first batch, and was evaluated It is a famous brand product in Fujian Province. In 2002, with the approval of the Ministry of personnel of the people's Republic of China, a postdoctoral research station was established. The company's shares were successfully listed on the Shanghai Stock Exchange on June 16, 2003. In 2003, it ranked 11th in the comprehensive performance of more than 1200 listed companies in China. In 2004, it was rated as the "top ten" performance of large, medium-sized state-owned and state-owned holding enterprises in Fujian Province. The company's leading product, pianzehuang, has twice won the national quality gold medal and has been listed in the first level national protection of traditional Chinese medicine. It is highly praised by patients at home and abroad for its unique anti-inflammatory, detoxification, analgesic, liver protection and other remarkable curative effects and health protection functions. It is known as the "national treasure drug" and exported to Southeast Asia, Japan, South Korea, Canada and other countries and regions, The annual export earnings exceed ten million US dollars, ranking first in the single export earnings of Chinese patent medicine. In 2000, as the first Chinese patent medicine research project funded by the Hong Kong government innovation and science and technology fund, the Chinese University of Hong Kong carried out the research on the liver protection effect of Pianzihuang. The company regards product quality as the life of the enterprise and organizes production in strict accordance with the requirements of GMP. The company always attaches great importance to the research and development of new drugs and the secondary development of old products. In recent years, more than ten new products including Jintangning capsule, Xinshubao tablet, Qingre Zhike granules, compound Pianzihuang buccal tablet, Zengyao and so on have been developed and put into production successively, which makes the company have new products on the market every year. The second development of old products -- clinical research on the indication of increasing Pianzihuang capsule has been listed in the "863" plan by the state. At present, the company has the following series of products: 1. Pianzihuang series: Pianzihuang, Pianzihuang capsule, compound Pianzihuang ointment, compound Pianzihuang hemorrhoids ointment, compound Pianzihuang buccal tablet; 2. Cold and cough series: Qingre Zhike granules, Chuanbei Qingfei syrup, Huoxiang Zhengqi water (capsule), Jinmu cold tablet, Xiaochaihu granules, Banlangen Granules, Xiaoer Zhike syrup, etc.; 3. Pills Series: Liuwei Dihuang pill, Qiju Dihuang pill, Zhibai Dihuang pill, Xiangsha Liujun pill, Xiaoyao Pill; 4. Liver protection and liver protection: yindanpinggan capsule, Hugan tablet; 5. Women and children: Zengyao, Xiaoyao Pill, Xiaoer cough syrup; 6. Cardiovascular: Xinshubao tablet, Fufang Danshen tablet; 7. Others: Shaolin zhenggujing, Niuhuang Jiedu tablet, bee milk capsule, Jintangning capsule, etc.; 8 In addition, there are only foreign products for sale: Longjiang brand special effect pianzehuang acne cream, compound pianzehuang Ganbao, pianzehuang Huoluo oil, pianzehuang Baihua snake antipruritic tablet, pianzehuang Runhou tablet, pianzehuang Xiaoyan capsule, pianzehuang Runhou sugar, pianzehuang drop hit essence, etc.

本文链接: https://www.waitui.com/brand/5a0277eda.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

马斯克怒怼《华尔街日报》:有损新闻业声誉

特斯拉CEO埃隆·马斯克连续发文回应《华尔街日报》,称其“有损新闻业声誉”,并表示“《华尔街日报》发布一篇蓄意造假的文章,且未纳入特斯拉董事会此前明确的否认声明,这是极其严重的违反职业道德行为!”此前,《华尔街日报》援引知情人士消息称,由于美国汽车制造商特斯拉公司股价下跌以及一些投资者对该公司首席执行官埃隆·马斯克关注白宫的举动感到不满,特斯拉董事会开始认真考虑寻找马斯克的继任者。随后,特斯拉方面澄清称,特斯拉董事长Robyn Denholm表示有关董事会已联系猎头公司寻找新任CEO的媒体报道“完全不实”。(新浪科技)

19分钟前

极氪科技集团4月销量41,316台,同比增长18.7%

36氪获悉,5月1日,极氪科技集团官微公布数据显示,2025年4月,旗下极氪和领克品牌共销售41316辆汽车,同比增长18.7%,环比增长1.5%。其中,旗下极氪品牌4月销量13,727台,领克品牌4月销量27,589台。4月集团上市2款新车,领克900上市1小时大定破万,极氪007GT进一步扩充热销猎装轿跑家族。截至目前,极氪科技集团已进入60多个国际主流市场,全球门店超1200家,全球用户超190万。

19分钟前

CounterPoint 报告 2025Q1 印度手机出货量:vivo 、三星 、OPPO居前三

CounterPoint Research近日发布了最新报告,2025年第一季度,印度智能手机市场在多重因素影响下,出货量同比下降7%。品牌竞争格局方面,具体出货量份额TOP5依次是:①vivo(22%份额)②三星(17%)③OPPO(15%)④小米(13%)⑤realme真我(11%),其它品牌合计约22%份额。(环球网科技)

19分钟前

深蓝汽车:4月全系交付20138辆 同比增长58%

36氪获悉,5月1日,深蓝汽车发布数据显示,今年4月全系交付20138辆,同比增长58%。

19分钟前

今年4月上海一二手房成交面积同比增21%,二手房成交2.07万套

记者从上海市房管局获悉,统计数据显示,今年4月,本市一二手住房合计成交231万平方米,同比增加21%,总体符合“金三银四”的市场运行规律。具体来看,一方面,一手住房市场保持平稳。新开盘项目认购较为稳定,在售项目销售良好,4月成交55万平方米,与去年同期基本持平;今年1~4月累计成交204万平方米,同比增加5%。另一方面,二手住房市场保持活跃。数据显示,4月,本市二手住房共成交176万平方米(2.07万套),同比增加32%,连续7个月超过1.5万套的荣枯线,为2022年以来同月最高值;今年1~4月累计成交667万平方米(7.85万套),同比增加45%。(澎湃新闻)

19分钟前

本页详细列出关于片仔癀药业的品牌信息,含品牌所属公司介绍,片仔癀药业所处行业的品牌地位及优势。
咨询